Zobrazeno 1 - 10
of 65
pro vyhledávání: '"A. M. Hövels"'
Autor:
J. M. van den Heuvel, A. M. Hövels, H. R. Büller, A. K. Mantel-Teeuwisse, A. de Boer, A. H. Maitland-van der Zee
Publikováno v:
Thrombosis Journal, Vol 16, Iss 1, Pp 1-10 (2018)
Abstract Background In 2012, around 400.000 patients in the Netherlands were treated with Vitamin K Antagonists (VKA) for thromboembolic diseases. Since 2011, non-VKA oral anticoagulants (NOACs) are available. NOACs do not require frequent INR monito
Externí odkaz:
https://doaj.org/article/27958c4f5cb74c558309e1cd43ca9ab5
Increasing the information provided by probabilistic sensitivity analysis: The relative density plot
Autor:
Joost W. Geenen, Rick A. Vreman, Cornelis Boersma, Olaf H. Klungel, Anke M. Hövels, Renske M. T. Ten Ham
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 18, Iss 1, Pp 1-10 (2020)
Abstract Background Results of probabilistic sensitivity analyses (PSA) are frequently visualized as a scatterplot, which is limited through overdrawing and a lack of insight in relative density. To overcome these limitations, we have developed the R
Externí odkaz:
https://doaj.org/article/2553ae0e6ad6472c8c4eede77ea9540f
Publikováno v:
Journal of Market Access & Health Policy, Vol 8, Iss 1 (2020)
Background: In many countries, Budget Impact (BI) informs reimbursement decisions. Evidence has shown that decision-makers have restricted access based on high BI estimates but studies show that BI estimates are often inaccurate. Objective: To assess
Externí odkaz:
https://doaj.org/article/31bee768a57a4f7b81d61f585da3c894
Autor:
Emma C. Hulshof, Mirjam de With, Femke M. de Man, Geert-Jan Creemers, Birgit A.L.M. Deiman, Jesse J. Swen, Saskia Houterman, Stijn L.W. Koolen, Sander Bins, Anna M.J. Thijs, Marjan M.J. Laven, Anke M. Hövels, Saskia A.C. Luelmo, Danny Houtsma, Katerina Shulman, Howard L. McLeod, Ron H.N. van Schaik, Henk-Jan Guchelaar, Ron H.J. Mathijssen, Hans Gelderblom, Maarten J. Deenen
Publikováno v:
European Journal of Cancer, 162, 148-157. Elsevier Ltd.
European Journal of Cancer, 162, 148-157. ELSEVIER SCI LTD
European Journal of Cancer, 162, 148-157. ELSEVIER SCI LTD
Aim: To determine the safety, feasibility, pharmacokinetics, and cost of UGT1A1 genotype-guided dosing of irinotecan.Patients and methods: In this prospective, multicentre, non-randomised study, patients intended for treatment with irinotecan were pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27f960399e216012a1be5fc64b0f0983
https://doi.org/10.1016/j.ejca.2021.12.009
https://doi.org/10.1016/j.ejca.2021.12.009
Autor:
Renske M.T. ten Ham, Alwin D. R. Huitema, Rick A. Vreman, Andre M. Bergman, Hilde Rosing, Merel van Nuland, Anke M. Hövels, Laurens G. de Graaf, Jos H. Beijnen
Publikováno v:
Value in Health. 24:121-128
Objectives Abiraterone acetate is registered for the treatment of metastatic castration-sensitive and resistant prostate cancer (mCRPC). Treatment outcome is associated with plasma trough concentrations (Cmin) of abiraterone. Patients with a plasma C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b8b6af34c83b1b893d65f35a013a8fb
https://doi.org/10.1016/j.jval.2020.04.1838
https://doi.org/10.1016/j.jval.2020.04.1838
Autor:
Ting Wang, Anke M. Hövels, Iga Lipska, Neil McAuslane, Lawrence Liberti, Hubert G. M. Leufkens
Publikováno v:
International Journal of Technology Assessment in Health Care. 36:332-348
ObjectivesThe objectives of the study were to establish a benchmarking tool to collect metrics to enable increased clarity regarding the differences and similarities across health technology assessment (HTA) agencies, to assess performance within and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62e690569011de33be84d18957ffb8a5
https://doi.org/10.1017/s0266462320000598
https://doi.org/10.1017/s0266462320000598
Autor:
Anke M. Hövels, Roger Tavendale, Colin N. A. Palmer, Stephen Bremner, Patrícia Soares, Christina J Jones, Jessie Felton, Katy Fidler, Somnath Mukhopadhyay
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical ImmunologyREFERENCES. 51(8)
The Fc Fragment of IgE Receptor II (FCER2) is expressed in several cells, such as macrophages, eosinophils, B cells and platelets. Studies have suggested that FCER2 is involved in the regulation of IgE responses, growth and differentiation of T and B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::803acad5a4d46052675bc8e5cb1f933d
https://pubmed.ncbi.nlm.nih.gov/34050993
https://pubmed.ncbi.nlm.nih.gov/34050993
Autor:
Sarah Maria Saragih, Olaf H. Klungel, T. I. Armina Padmasawitri, Gerardus W. Frederix, Anke M. Hövels
Publikováno v:
PharmacoEconomics-Open, 4(2), 223. Springer Nature Switzerland AG
PharmacoEconomics Open
PharmacoEconomics Open
Background Limited evidence for the implementation of new health technologies in low- and middle-income countries (LMICs) may lead to uncertainties in economic evaluations and cause the evaluations to produce inaccurate information for decision makin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfdb80c3f2ee0a04dac6d8220a71aac
https://dspace.library.uu.nl/handle/1874/410825
https://dspace.library.uu.nl/handle/1874/410825
Autor:
Gerard H. Koppelman, Anke M. Hövels, Marielle W. Pijnenburg, Anke-Hilse Maitland-van der Zee, Susanne J. H. Vijverberg
Publikováno v:
Pharmacogenomics, 18(4), 393-401. FUTURE MEDICINE LTD
Pharmacogenomics, 18(4), 393-401. Future Medicine Ltd.
Pharmacogenomics, 18(4), 393-401. Future Medicine Ltd.
A ‘one-size fits all’-approach does not fit all pediatric asthma patients. Current evidence suggests that in children with persistent asthma, ADRB2 genotype-guided treatment can improve treatment outcomes, yet this evidence is mainly derived from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8086b81ed521bf9cf36ecadaf001764e
https://doi.org/10.2217/pgs-2016-0174
https://doi.org/10.2217/pgs-2016-0174
Autor:
Rob ter Heine, Marco van Vulpen, Anko Kooistra, Geert W.J. Frederix, Anke M. Hövels, Haiko J. Bloemendal, Joost W Geenen, John M. H. de Klerk
Publikováno v:
Journal of Comparative Effectiveness Research, 6, 7, pp. 575-581
Journal of Comparative Effectiveness Research, 6, 575-581
Journal of Comparative Effectiveness Research, 6, 575-581
Aim: To assess the resource use and associated costs of treating patients with metastatic prostate cancer with a focus on skeletal-related events (SREs). Methods: We performed a bottom-up cost of illness study in The Netherlands. Results: A total of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aea1262d7f3058587aa6790749f909e
https://hdl.handle.net/2066/182725
https://hdl.handle.net/2066/182725